Recessive mutations in SCYL2 cause a novel syndromic form of arthrogryposis in humans

Hum Genet. 2020 Apr;139(4):513-519. doi: 10.1007/s00439-020-02117-7. Epub 2020 Jan 20.

Abstract

Arthrogryposis multiplex congenita (AMC) is an important birth defect with a significant genetic contribution. Many syndromic forms of AMC have been described, but remain unsolved at the molecular level. In this report, we describe a novel syndromic form of AMC in two multiplex consanguineous families from Saudi Arabia and Oman. The phenotype is highly consistent, and comprises neurogenic arthrogryposis, microcephaly, brain malformation (absent corpus callosum), optic atrophy, limb fractures, profound global developmental delay, and early lethality. Whole-exome sequencing revealed a different homozygous truncating variant in SCYL2 in each of the two families. SCYL2 is a component of clathrin-coated vesicles, and deficiency of its mouse ortholog results in a severe neurological phenotype that largely recapitulates the phenotype observed in our patients. Our results suggest that severe neurogenic arthrogryposis with brain malformation is the human phenotypic consequence of SCYL2 loss of function mutations.

Publication types

  • Case Reports
  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adult
  • Arthrogryposis* / diagnostic imaging
  • Arthrogryposis* / genetics
  • Arthrogryposis* / pathology
  • Child, Preschool
  • Female
  • Genes, Recessive*
  • Humans
  • Infant
  • Infant, Newborn
  • Loss of Function Mutation*
  • Male
  • Pedigree*
  • Protein Serine-Threonine Kinases / genetics*
  • Syndrome

Substances

  • Protein Serine-Threonine Kinases
  • SCYL2 protein, human